Ovarian Hyperstimulation Syndrome Prevention (OHSS)

Aljazeera Hospital

Status: Enrolling

Conditions: Ovarian Hyper Stimulation Syndrome (OHSS)

Treatments: Drug: Modified Agonist protocol for IVF with additive treatments as HCQ; Drug: Antagonist protocol for IVF

Study type: Interventional

Funder types: Other

Identifiers

NCT06739759

ovarian hyperstimulation

Details and patient eligibility

About

Ovarian hyperstimulation is a very hazardous complication of ICSI

Full description

Ovarian hyperstimulation could be mild , moderate , severe or marked

Enrollment: 300 estimated patients

Sex: Female

Ages: 19 to 42 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Women with PCOS coming for ICSI

Exclusion criteria

• Women who donnot have PCOS

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

300 participants in 2 patient groups

antagonist

Active Comparator group

Description:

patients with PCOS undergoing ICSI receiving antagonist protocol

Treatment:

Drug: Antagonist protocol for IVF

Modified agonist with additives

Active Comparator group

Description:

Patients with PCOS undergoing ICSI receiving modified agonist protocol with additives

Treatment:

Drug: Modified Agonist protocol for IVF with additive treatments as HCQ